Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 -0.03 (0.29%)
Previous Close $10.22    52 Week High $9.23 
Open $10.10    52 Week Low $1.16 
Day High $10.36    P/E N/A 
Day Low $9.75    EPS $-0.30 
Volume 4,230,752       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 -0.03 (0.29%)
Previous Close $10.22    52 Week High $9.23 
Open $10.10    52 Week Low $1.16 
Day High $10.36    P/E N/A 
Day Low $9.75    EPS $-0.30 
Volume 4,230,752